Nater Dallafior advised and represented a Swiss-domiciled company – being the policyholder – against its insurer in connection with the policyholder’s claim for coverage based on a business interruption insurance policy. The policyholder is active in
ADC Therapeutics, a Lausanne-based commercial-stage oncology-focused biotechnology company, has entered into a royalty purchase agreement with HealthCare Royalty. Under the agreement, ADC Therapeutics will receive up to USD 325 million. Initial payment of USD 225 million upon
The persistent low interest rate environment over the past few years has prompted changes in the life insurance industry. Against this backdrop, Allianz Suisse Lebensversicherungs-Gesellschaft and the reinsurance company Resolution Re have agreed on an
Aryzta, a global food business based in Switzerland and listed on the SIX, has entered into an underwritten agreement with three banks for a new €500 million revolving credit facility. The facility which is expected to
Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focused on the development and commercialisation of innovative medicines for rare neuromuscular neuromuscular and pulmonary diseases with high unmet medical need, has announced an equity financing of CHF 20
Frontify, the provider of brand management software, has successfully raised an additional USD 50m in Series C funding, led by Revaia (formerly Gaia Capital Partners) with participation from HighSage Ventures and existing investors EQT Ventures,
Pestalozzi advises global institutional investors (“Investors”) in connection with an amendment to the up to $44,000,000 equity linked investment in WISeKey International Holding (“WISeKey”) listed at SIX Swiss Exchange and with ADS traded at NASDAQ, agreed
Climeworks announced the launch of “Orca”, the world’s largest climate-positive carbon dioxide direct air capture (DAC) and storage plant in Hellisheidi, Iceland. The first of its kind plant will remove carbon dioxide from the
Homburger acted as Swiss legal counsel to 21Shares, a Zug-based special purpose issuance vehicle of the fintech group Amun and the Swiss market leader in crypto- linked exchange traded products (ETPs), in the successful issuance
Ultra Forensic Technology (UFT) has agreed to sell its Switzerland based Projectina business (Projectina) to UK-based private equity and advisory firm, Heligan Group. As a niche forensic and security-focused optical engineering business, Projectina has been
